{"id":"7b7769fe-096e-4fc7-bb58-4d1738730000","kind":"news","code":"7b7769fe-096e-4fc7-bb58-4d1738730000","name":"Omniscient Neurotechnology raises USD 27.2 million in Series D financing","nameBasis":"translated-title","summary":"On 2026-06-02, according to Xiniu Data, Omniscient Neurotechnology completed Series D financing, raising USD 27.2 million. Investors were co-lead investor OIF Ventures, co-lead investor National Reconstruction Fund Corporation, participating investor Will Vicars, participating investor Gina Rinehart AO. The company is an Australian provider of treatments for neuropsychiatric disorders.","description":"","country":null,"category":null,"originalName":"Omniscient Neurotechnology完成D轮融资，金额2720万美元","eventDate":"2026-06-02T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-19T05:58:28.520Z","englishUpdatedAt":"2026-10-20T18:21:37.541Z","reviewedAt":"2026-10-20T18:21:37.541Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"5f920fd2ce12ef3169e949664ba691a774e3621ccbf69e029370c122707e6a66","companyId":"0a21105f-9847-48ae-b00f-b31fdea2e45d","foundedYear":null,"logoUrl":null,"originalText":"2026年6月2日，据烯牛数据报道，Omniscient Neurotechnology完成D轮融资，金额2720万美元。投资方为OIF Ventures、National Reconstruction Fund Corporation领投，Will Vicars、Gina Rinehart AO跟投。该公司为澳大利亚神经精神疾病治疗方案提供商。","sources":[],"related":[{"id":"27aa0adb-24ad-45c0-8191-017c66803952","kind":"institutions","code":"UB-I7830","name":"Gina Rinehart AO","nameBasis":"original-brand","summary":"Gina Rinehart, an individual investor.","description":"Gina Rinehart, an individual investor.","country":null,"category":null,"originalName":"Gina Rinehart AO","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:20.019Z","englishUpdatedAt":"2026-10-16T01:39:37.660Z","reviewedAt":"2026-10-16T01:39:37.660Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"eb0f4f9530ebc0127be42863fc9b9c8df9bc130bf10fbf7bf2bdbafec2280b52","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gina-rinehart-ao"},{"id":"0f4d3775-b923-46fc-9ce9-fc787358e06e","kind":"institutions","code":"UB-I1705","name":"National Reconstruction Fund Corporation","nameBasis":"original-brand","summary":"Australia's National Reconstruction Fund, a government industrial investment organization.","description":"Australia's National Reconstruction Fund, a government industrial investment organization.","country":null,"category":null,"originalName":"National Reconstruction Fund Corporation","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:21.725Z","englishUpdatedAt":"2026-10-15T20:44:29.304Z","reviewedAt":"2026-10-15T20:44:29.304Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ed60228774cd788986f80f9bbc293b31488137b1243c3df92a05fed77bd497fc","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/national-reconstruction-fund-corporation"},{"id":"a6f9e05c-c3aa-46b3-be51-1cae54130a64","kind":"institutions","code":"UB-I130","name":"OIF Ventures","nameBasis":"original-brand","summary":"OIF Ventures is a venture capital firm, focused on investment in seed- to growth-stage companies.","description":"OIF Ventures is a venture capital firm, focused on investment in seed- to growth-stage companies.","country":null,"category":null,"originalName":"OIF Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:24.440Z","englishUpdatedAt":"2026-10-15T18:21:17.226Z","reviewedAt":"2026-10-15T18:21:17.226Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"1da2cbfed2407c9f04d888bdc5f36786b02adfe90feb9ccd6518e5432b8cbf52","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/oif-ventures"},{"id":"0a21105f-9847-48ae-b00f-b31fdea2e45d","kind":"companies","code":"UB-C10195","name":"Omniscient Neurotechnology","nameBasis":"source-english","summary":"Australian provider of treatments for neuropsychiatric disorders.","description":"Australian provider of treatments for neuropsychiatric disorders.","country":"Australia","category":null,"originalName":"Omniscient Neurotechnology","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:21:34.928Z","reviewedAt":"2026-10-20T18:21:34.928Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"c26394ef45b54982c0e20c386b17adf907aeb520e39030a81b6edbfeacc409eb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/omniscient-neurotechnology"},{"id":"d0dd5d1e-27bf-4a19-bce4-ed0f122b1a1d","kind":"institutions","code":"UB-I7891","name":"Will Vicars","nameBasis":"original-brand","summary":"Will Vicars, an individual investor.","description":"Will Vicars, an individual investor.","country":null,"category":null,"originalName":"Will Vicars","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:20.013Z","englishUpdatedAt":"2026-10-16T01:39:37.938Z","reviewedAt":"2026-10-16T01:39:37.938Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"d7c385906ac5cf614165210885e253011b35188304730c08c97d86bd038e0b6f","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/will-vicars"}],"path":"/news/7b7769fe-096e-4fc7-bb58-4d1738730000","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Omniscient Neurotechnology","path":"/companies/omniscient-neurotechnology"}},"canonical":"https://uniquebase.ai/news/7b7769fe-096e-4fc7-bb58-4d1738730000"}